Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial by Mark Jones, Gagandeep Kang, Thomas L Snelling, Vivekanand Jha, Vinay Rathore, Stephane Heritier, Meg Jardine, Kapil Soni, James Totterdell, Sradha Kotwal, Guy Thwaites, Cheryl Jones, Carol Pollock, Richard Haynes, Katrina Diamante, Abhinav Bassi, Nikita Bathla, Natalie Staplin, Arlen Wilcox, Ashpak Bangi, Gregory Fox, Atul Jindal, Rui Xie, Daniel Vincent O'Hara, Sanjay D'Cruz, Manish Kumar Jain, Louise Burrell, Sharifah Faridah Syed Omar, Gerard Estivill Mercade, Aishwarya Nair, Annelise Decaria, Nicola Abignano, Sabah Siddiqui, Suprava Patel, Anjulata Sahu, Yasmeen Shaikh, Madhavender Jain, Shivam R Kanje, Sanjeev Kumar Vimal, K. Kalyan Chakravarthy, P. Sathish Babu, Yuvraj Singh Cheema, Merlin Moni, Sivapriya G Nair

Get full text